Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Although there has been a rise in the popularity of fillers and injectables over recent years, many beauty enthusiasts are ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Our earbuds combine real-time measurement and customized sound therapy in a single device,” CEO and founder Seungpyo Noh told ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

This study found that oxytocin had particularly strong effects in women, promoting lower blood pressure and reducing norepinephrine, a hormone associated with the body’s stress response. Additionally, ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Age-Related Hearing Loss (ARHL) is a prevalent condition affecting a significant portion of the elderly population worldwide. It is characterized by a ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...